{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:53:40Z","timestamp":1793505220466,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Mechanical thrombectomy for the treatment of deep vein thrombosis (DVT) is being increasingly utilized to reduce symptoms and prevent postthrombotic syndrome (PTS), but more data on clinical outcomes are needed. Mechanical thrombectomy was studied in the ClotTriever Outcomes (CLOUT) registry with 6-month full analysis outcomes reported herein.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>The CLOUT registry is a prospective, all-comer study that enrolled 500 lower extremity DVT patients across 43 US sites treated with mechanical thrombectomy using the ClotTriever System. Core-lab assessed Marder scores and physician-assessed venous patency by duplex ultrasound, PTS assessment using Villalta score, venous symptom severity, pain, and quality of life scores through 6\u00a0months were analyzed. Adverse events were identified and independently adjudicated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      All-cause mortality at 30\u00a0days was 0.9%, and 8.6% of subjects experienced a serious adverse event (SAE) within the first 30\u00a0days, 1 of which (0.2%) was device related. SAE rethrombosis\/residual thrombus incidence was 4.8% at 30\u00a0days and 8.0% at 6\u00a0months. Between baseline and 6\u00a0months, venous flow increased from 27.2% to 92.5% of limbs (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001), and venous compressibility improved from 28.0% to 91.8% (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001), while median Villalta scores improved from 9.0 at baseline to 1.0 at 6\u00a0months (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Significant improvements in venous symptom severity, pain, and quality of life were also demonstrated. Outcomes from iliofemoral and isolated femoral-popliteal segments showed similar improvements.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Outcomes from the CLOUT study, a large prospective registry for DVT, indicate that mechanical thrombectomy is safe and demonstrates significant improvement in symptoms and health status through 6\u00a0months.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Level of Evidence<\/jats:italic>\n                      3: Non-randomized controlled cohort\/follow-up study.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00270-023-03509-8","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T16:04:16Z","timestamp":1692029056000},"page":"1571-1580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Six-Month Outcomes of Mechanical Thrombectomy for Treating Deep Vein Thrombosis: Analysis from the 500-Patient CLOUT Registry"],"prefix":"10.1007","volume":"46","author":[{"given":"Abdullah","family":"Shaikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Zybulewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Paulisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohannad","family":"Bisharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas J.","family":"Mouawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Abramowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lindquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezana","family":"Azene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Cockrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavraj","family":"Khalsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Khetarpaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Douglas A.","family":"Murrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyan","family":"Veerina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edvard","family":"Skripochnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Bunte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Annambhotla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Schor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Kado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Mojibian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dexter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the CLOUT Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"key":"3509_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1182\/asheducation-2016.1.413","volume":"2016","author":"SR Kahn","year":"2016","unstructured":"Kahn SR. The post-thrombotic syndrome. Hematology Am Soc Hematol Educ Progr. 2016;2016:413\u20138.","journal-title":"Hematology Am Soc Hematol Educ Progr"},{"key":"3509_CR2","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","volume":"160","author":"SM Stevens","year":"2021","unstructured":"Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. 2021;160:e545\u2013608.","journal-title":"Chest"},{"key":"3509_CR3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.7326\/0003-4819-152-9-201005040-00008","volume":"152","author":"M Carrier","year":"2010","unstructured":"Carrier M, Le Gal G, Wells PS, Rodger MA. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med. 2010;152:578\u201389.","journal-title":"Ann Intern Med"},{"key":"3509_CR4","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1007\/s00330-022-08599-5","volume":"32","author":"C Arnoldussen","year":"2022","unstructured":"Arnoldussen C, Notten P, Brans R, et al. Clinical impact of assessing thrombus age using magnetic resonance venography prior to catheter-directed thrombolysis. Eur Radiol. 2022;32:4555\u201364.","journal-title":"Eur Radiol"},{"key":"3509_CR5","doi-asserted-by":"publisher","first-page":"955","DOI":"10.7326\/0003-4819-137-12-200212170-00008","volume":"137","author":"P Prandoni","year":"2002","unstructured":"Prandoni P, Lensing AW, Prins MH, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med. 2002;137:955\u201360.","journal-title":"Ann Intern Med"},{"key":"3509_CR6","volume":"2","author":"DJ Dexter","year":"2023","unstructured":"Dexter DJ, Kado H, Shaikh A, et al. Safety and effectiveness of mechancial thrombectomy from the fully enrolled multicenter, prospective CLOUT registry. JSCAI. 2023;2: 100585.","journal-title":"JSCAI"},{"key":"3509_CR7","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jvsv.2022.02.013","volume":"10","author":"DJ Dexter","year":"2022","unstructured":"Dexter DJ, Kado H, Schor J, et al. Interim outcomes of mechanical thrombectomy for deep vein thrombosis from the All-comer CLOUT Registry. J Vasc Surg Venous Lymphat Disord. 2022;10:832-840.e2.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"3509_CR8","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.jvs.2004.09.027","volume":"40","author":"B Ekl\u00f6f","year":"2004","unstructured":"Ekl\u00f6f B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248\u201352.","journal-title":"J Vasc Surg"},{"key":"3509_CR9","unstructured":"ISO 14155:2020 Clinical investigation of medical devices for human subjects - Good clinical practice. 2020."},{"key":"3509_CR10","first-page":"1018","volume":"89","author":"VJ Marder","year":"1977","unstructured":"Marder VJ, Soulen RL, Atichartakarn V, et al. Quantitative venographic assessment of deep vein thrombosis in the evaluation of streptokinase and heparin therapy. J Lab Clin Med. 1977;89:1018\u201329.","journal-title":"J Lab Clin Med"},{"key":"3509_CR11","first-page":"158a","volume":"24","author":"S Villalta","year":"1994","unstructured":"Villalta S, Bagatella P, Piccioli A, Lensing AW, Prins MH, Prandoni P. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome (abstract). Haemostasis. 1994;24:158a.","journal-title":"Haemostasis"},{"key":"3509_CR12","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.jvs.2010.06.161","volume":"52","author":"MA Vasquez","year":"2010","unstructured":"Vasquez MA, Rabe E, McLafferty RB, et al. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg. 2010;52:1387\u201396.","journal-title":"J Vasc Surg"},{"key":"3509_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jvsv.2012.10.059","volume":"1","author":"WA Marston","year":"2013","unstructured":"Marston WA, Vasquez MA, Lurie F, et al. Multicenter assessment of the repeatability and reproducibility of the revised Venous Clinical Severity Score (rVCSS). J Vasc Surg Venous Lymphat Disord. 2013;1:219\u201324.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"3509_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0168-8510(91)90142-K","volume":"18","author":"RG Brooks","year":"1991","unstructured":"Brooks RG, Jendteg S, Lindgren B, Persson U, Bj\u00f6rk S. EuroQol: health-related quality of life measurement. Results of the Swedish questionnaire exercise. Health Policy. 1991;18:37\u201348.","journal-title":"Health Policy"},{"key":"3509_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-002984","volume":"3","author":"T Enden","year":"2013","unstructured":"Enden T, Wik HS, Kvam AK, Haig Y, Kl\u00f8w NE, Sandset PM. Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study. BMJ Open. 2013;3: e002984.","journal-title":"BMJ Open"},{"key":"3509_CR16","unstructured":"Team RC. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2021:https:\/\/www.R-project.org\/."},{"key":"3509_CR17","first-page":"11","volume":"10","author":"GP Liu","year":"2013","unstructured":"Liu GP, Ge MY, Li L, et al. Analysis on dose and effect of urokinase in patients with lower limb deep vein thrombosis treated with catheter-directed thrombolysis. Chinese J Interv Imaging Ther. 2013;10:11\u20134.","journal-title":"Chinese J Interv Imaging Ther"},{"key":"3509_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jvsv.2020.08.029","volume":"9","author":"V Lakhter","year":"2021","unstructured":"Lakhter V, Zack CJ, Brailovsky Y, et al. Predictors of intracranial hemorrhage in patients treated with catheter-directed thrombolysis for deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2021;9:627-634.e2.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"3509_CR19","first-page":"cd002783","volume":"1","author":"C Broderick","year":"2021","unstructured":"Broderick C, Watson L, Armon MP. Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb. Cochrane Database Syst Rev. 2021;1:cd002783.","journal-title":"Cochrane Database Syst Rev"},{"key":"3509_CR20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jvir.2013.02.023","volume":"24","author":"RJ Kennedy","year":"2013","unstructured":"Kennedy RJ, Kenney HH, Dunfee BL. Thrombus resolution and hemodynamic recovery using ultrasound-accelerated thrombolysis in acute pulmonary embolism. J Vasc Interv Radiol. 2013;24:841\u20138.","journal-title":"J Vasc Interv Radiol"},{"key":"3509_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2022.10.011","author":"Y Tian","year":"2022","unstructured":"Tian Y, Shi CH, Lu WL, et al. Risk factors and outcomes regarding the acute kidney injury after AngioJet thrombectomy for acute lower-extremity deep vein thrombosis. Asian J Surg. 2022. https:\/\/doi.org\/10.1016\/j.asjsur.2022.10.011.","journal-title":"Asian J Surg"},{"key":"3509_CR22","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.ejvs.2020.05.006","volume":"60","author":"AL Pouncey","year":"2020","unstructured":"Pouncey AL, Gwozdz AM, Johnson OW, et al. AngioJet pharmacomechanical thrombectomy and catheter directed thrombolysis vs. catheter directed thrombolysis alone for the treatment of iliofemoral deep vein thrombosis: a single centre retrospective cohort study. Eur J Vasc Endovasc Surg. 2020;60:578\u201385.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"3509_CR23","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa1615066","volume":"377","author":"S Vedantham","year":"2017","unstructured":"Vedantham S, Goldhaber SZ, Julian JA, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med. 2017;377:2240\u201352.","journal-title":"N Engl J Med"},{"key":"3509_CR24","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/S2352-3026(19)30209-1","volume":"7","author":"P Notten","year":"2020","unstructured":"Notten P, Ten Cate-Hoek AJ, Arnoldussen C, et al. Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. Lancet Haematol. 2020;7:e40\u20139.","journal-title":"Lancet Haematol"},{"key":"3509_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(11)61753-4","volume":"379","author":"T Enden","year":"2012","unstructured":"Enden T, Haig Y, Kl\u00f8w NE, et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet. 2012;379:31\u20138.","journal-title":"Lancet"},{"key":"3509_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jvsv.2017.12.059","volume":"6","author":"T Yoo","year":"2018","unstructured":"Yoo T, Aggarwal R, Wang TF, Satiani B, Haurani MJ. Presence and degree of residual venous obstruction on serial duplex imaging is associated with increased risk of recurrence and progression of infrainguinal lower extremity deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2018;6:575-583.e1.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"3509_CR27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ejvs.2012.04.016","volume":"44","author":"F Aziz","year":"2012","unstructured":"Aziz F, Comerota AJ. Quantity of residual thrombus after successful catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with recurrence. Eur J Vasc Endovasc Surg. 2012;44:210\u20133.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"3509_CR28","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1055\/s-0038-1666859","volume":"118","author":"CEA Dronkers","year":"2018","unstructured":"Dronkers CEA, Mol GC, Maraziti G, et al. Predicting post-thrombotic syndrome with ultrasonographic follow-up after deep vein thrombosis: a systematic review and meta-analysis. Thromb Haemost. 2018;118:1428\u201338.","journal-title":"Thromb Haemost"},{"key":"3509_CR29","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1111\/j.1538-7836.2006.02120.x","volume":"4","author":"L Young","year":"2006","unstructured":"Young L, Ockelford P, Milne D, Rolfe-Vyson V, McKelvie S, Harper P. Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality. J Thromb Haemost. 2006;4:1919\u201324.","journal-title":"J Thromb Haemost"},{"key":"3509_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1160\/TH13-04-0336","volume":"111","author":"MP Donadini","year":"2014","unstructured":"Donadini MP, Ageno W, Antonucci E, et al. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis. Thromb Haemost. 2014;111:172\u20139.","journal-title":"Thromb Haemost"},{"key":"3509_CR31","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/S2352-3026(15)00248-3","volume":"3","author":"Y Haig","year":"2016","unstructured":"Haig Y, Enden T, Gr\u00f8tta O, et al. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol. 2016;3:e64-71.","journal-title":"Lancet Haematol"},{"key":"3509_CR32","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.jvir.2020.07.010","volume":"31","author":"MK Razavi","year":"2020","unstructured":"Razavi MK, Salter A, Goldhaber SZ, et al. Correlation between post-procedure residual thrombus and clinical outcome in deep vein thrombosis patients receiving pharmacomechanical thrombolysis in a multicenter randomized trial. J Vasc Interv Radiol. 2020;31:1517-1528.e2.","journal-title":"J Vasc Interv Radiol"},{"key":"3509_CR33","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1161\/CIRCULATIONAHA.118.037425","volume":"139","author":"AJ Comerota","year":"2019","unstructured":"Comerota AJ, Kearon C, Gu CS, et al. Endovascular thrombus removal for acute Iliofemoral deep vein thrombosis. Circulation. 2019;139:1162\u201373.","journal-title":"Circulation"},{"key":"3509_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1055\/s-0039-1677795","volume":"119","author":"C Kearon","year":"2019","unstructured":"Kearon C, Gu CS, Julian JA, et al. Pharmacomechanical catheter-directed thrombolysis in acute femoral-popliteal deep vein thrombosis: analysis from a stratified randomized trial. Thromb Haemost. 2019;119:633\u201344.","journal-title":"Thromb Haemost"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-023-03509-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-023-03509-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-023-03509-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T12:03:58Z","timestamp":1698667438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-023-03509-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["3509"],"URL":"https:\/\/doi.org\/10.1007\/s00270-023-03509-8","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"29 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Abdullah Shaikh, MD, is a speaker for Inari Medical.\u00a0Mohannad Bisharat, MD, is a consultant for Inari Medical.\u00a0Nicolas J. Mouawad, MD, MPH, MBA, is a consultant for Inari Medical and Boston Scientific. Eugene Ichinose, MD, is a consultant for Inari Medical, Penumbra, and Angiodynamics, and is a speaker for Pfizer and Bristol Meyers Squib.\u00a0Steven Abramowitz, MD\u00a0is a speaker for Inari Medical. Jonathan Lindquist, MD, receives grant support from Inari Medical, Boston Scientific, Sirtex Medical, Philips, is a consultant for Inari Medical, Boston Scientific, Avantec Vascular, Endoshape, Inc., Philips, and Trisalu Life Sciences; and is on the advisory board of Avantec Vascular. Bhavraj Khalsa, MD, is a consultant for Inari Medical. Kalyan Veerina, MD\u00a0is a speaker for Inari Medical. Thomas S. Maldonado, MD, is a consultant for Inari Medical. Matthew C. Bunte, MD, MS, receives grant support from Inari Medical, and is a consultant for Abbott, Shockwave Medical, and Inari Medical.Adam Zybulewski, MD, Joseph Paulisin, DO, Adam Raskin, MD, Ezana Azene, MD, PhD, Neil Shah, MD, James Nguyen, MD, Josh Cockrell, MD, Vipul Khetarpaul, MD, Douglas A. Murrey Jr., MS, MD, Edvard Skripochnik, MD, Suman Annambhotla, MD, report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}